DEXMDERM Trademark

Trademark Overview


On Thursday, February 28, 2019, a trademark application was filed for DEXMDERM with the United States Patent and Trademark Office. The USPTO has given the DEXMDERM trademark a serial number of 88320210. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 27, 2023. This trademark is owned by Teikoku Pharma USA, Inc.. The DEXMDERM trademark is filed in the Pharmaceutical Products category with the following description:

Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or substance withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation, namely, sedatives, anaesthetics, general anesthetics, anesthetic for surgical use, anesthetics for non-surgical use; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety, Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of substance withdrawal syndromes; Pharmaceutical preparations, namely, topical preparations for use in the management of pain; Pharmaceutical preparations, namely, topical preparations for use in providing sedation, namely, sed...
dexmderm

General Information


Serial Number88320210
Word MarkDEXMDERM
Filing DateThursday, February 28, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements


Goods and ServicesTransdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or substance withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation, namely, sedatives, anaesthetics, general anesthetics, anesthetic for surgical use, anesthetics for non-surgical use; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety, Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of substance withdrawal syndromes; Pharmaceutical preparations, namely, topical preparations for use in the management of pain; Pharmaceutical preparations, namely, topical preparations for use in providing sedation, namely, sedatives, anaesthetics, general anesthetics, anesthetic for surgical use, anesthetics for non-surgical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeikoku Pharma USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Jose, CA 951311711

Party NameTeikoku Pharma USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Jose, CA 951311711

Trademark Events


Event DateEvent Description
Monday, March 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 22, 2022SOU EXTENSION 5 GRANTED
Friday, August 12, 2022SOU EXTENSION 5 FILED
Monday, August 22, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 12, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 11, 2022SOU EXTENSION 4 GRANTED
Friday, February 11, 2022SOU EXTENSION 4 FILED
Friday, February 11, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 13, 2021SOU EXTENSION 3 GRANTED
Friday, August 13, 2021SOU EXTENSION 3 FILED
Friday, August 13, 2021SOU TEAS EXTENSION RECEIVED
Thursday, February 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 9, 2021SOU EXTENSION 2 GRANTED
Tuesday, February 9, 2021SOU EXTENSION 2 FILED
Tuesday, February 9, 2021SOU TEAS EXTENSION RECEIVED
Thursday, August 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 11, 2020SOU EXTENSION 1 GRANTED
Tuesday, August 11, 2020SOU EXTENSION 1 FILED
Tuesday, August 11, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 12, 2019ASSIGNED TO LIE
Tuesday, November 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 9, 2019NON-FINAL ACTION E-MAILED
Thursday, May 9, 2019NON-FINAL ACTION WRITTEN
Thursday, May 9, 2019ASSIGNED TO EXAMINER
Wednesday, March 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 4, 2019NEW APPLICATION ENTERED